Skip to main content

Oral question asked in the House of Commons, by Stephen Ladyman (Labour). It was answered on Thursday, 14 May 1998 on behalf of the Department of Trade and Industry.


Dept of Trade and Industry

Question
1st supplementary on effect of staff investment on competitiveness and success of Pfizer.

Secondary information

Type
Oral question
Reference
312 c511-2;312 c513-4 
Session
1997-98
Oral question type
1st Supplementary
Chamber / Committee
House of Commons chamber
Subjects
Business Competition Pfizer Competitiveness UK initiative